Brian Coe is Chief Executive Officer and co-founder of SlipChip Corporation, which is developing a micro-fluidic platform for conducting quantitative molecular and measurement assays in research and clinical laboratories. He currently serves as Chairman of Euclid Diagnostics, an epigenetics company he co-founded, and is the Entrepreneur-in-Residence for healthcare at the Michael P. Polsky Center for Entrepreneurship at the University of Chicago Booth School of Business.
Previously, Mr. Coe was a Senior Vice President at The Laboratory Corporation of America (NYSE:LH) and Co-Chairman of its Clinical Decision Support Committee. Prior to joining LabCorp, he co-founded and served as the Chief Executive Officer of Litholink Corporation, a specialty laboratory that provided sophisticated clinical decision support embedded into its reports in order to help physicians manage recurrent kidney stone formation. LabCorp acquired Litholink in November 2006.
Mr. Coe earned an MBA from Chicago Booth and a BA in neuroscience and psychology from Brandeis University.